Why has there been so little progress on Alzheimer's disease? (freakonomics.com)

Article summary

The article discusses the lack of progress in Alzheimer's disease research, with a focus on the potential role of fraudulent science in hindering advancements. A leading hypothesis, the amyloid hypothesis, has been widely pursued, but some researchers and journalists are now questioning its validity. The article highlights the work of Charles Piller, an investigative journalist, and Matthew Schrag, a neuroscientist, who have uncovered problematic research and are seeking to understand the true causes of Alzheimer's. The disease remains a complex and poorly understood condition, with many factors contributing to its development and progression.

Main themes

• Alzheimer's disease research
• scientific fraud
• amyloid hypothesis
• complexity of disease
• research funding
• gatekeepers in science
• innovation and exploration
• private funding and bias

What commenters say

• The amyloid hypothesis has been a dominant theory in Alzheimer's research, but its validity is now being questioned due to potential scientific fraud.
• The lack of progress in Alzheimer's research is not solely due to fraud, but also due to the complexity of the disease and the challenges of studying it.
• Gatekeepers in the scientific community have stifled innovation and exploration of alternative theories, contributing to the slow progress in Alzheimer's research.
• The allocation of research funding is often controlled by a small group of experts, which can lead to a lack of diversity in research approaches and a focus on established theories.
• Some researchers believe that Alzheimer's is a complex disease with multiple causes, and that a single theory or approach is unlikely to be effective in understanding or treating it.
• The scientific community has a tendency to cling to established theories, even when they are proven to be incorrect, and this can hinder progress in research and understanding of diseases like Alzheimer's.
• Private funding for research can be influenced by personal interests and biases, rather than solely by scientific merit, which can also impact the direction of research.
• The complexity of Alzheimer's disease and the lack of understanding of its causes mean that it is difficult to develop effective treatments, and that a more nuanced and multifaceted approach to research is needed.